Tele-rehabilitation in Women With Breast Cancer During COVID-19 Pandemic.
Use of a Tele-rehabilitation Platform to Enable Physical Activity in Women With Breast Cancer During the Quarantine Period Due to COVID-19.
1 other identifier
interventional
60
1 country
1
Brief Summary
Introduction: Cancer is the main public health problem in the world and is already among the main causes of death. Breast CA will be the second most common type of cancer in the Brazilian population between 2020-2022. The pandemic caused by COVID-19 brought several changes in society, affecting health services, one of which was the need to maintain regular treatment for various health conditions, such as cancer. Physical therapy is an essential part of the multidisciplinary treatment of cancer patients. With the new technologies available, it is possible to allow continuous treatment of cancer patients, even during quarantine, and one possibility is the application of information and communication technologies to provide rehabilitation therapy to remote people, called home telerehabilitation. Objective: To verify the effect of virtual reality (VR) training on motor performance, pain and heart rate variability variables in patients diagnosed with breast cancer. Methods: The study will be composed of 30 women over 18 years old with a diagnosis of breast cancer attended at an oncology physical therapy clinic in the city of Juiz de Fora - MG. Participants will undergo training using virtual reality technology, always guided by the researcher. There will be a total of 10 (ten) interventions, with two training sessions per week. The participant will be guided by a researcher who will instruct her online. Five games will be used: Reaction Time, Coincident Timing, Fitts, Genius, MoveHero. Participants will answer some questionnaires and scales such as EORTC QLQ-C30 which assesses quality of life in cancer patients, perceived exertion scale will be applied before and between matches, a mood scale (BRUMS) will be applied at the beginning and at the end of training and Affective Analog Face Scale for pain assessment and analysis of Heart Rate Variability (HRV) that will be performed before, during and after the first and last training, through a heart rate monitor that will be given to each participant and an application cell phone (Elite HRV).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable breast-cancer
Started Mar 2020
Typical duration for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 2, 2021
CompletedFirst Submitted
Initial submission to the registry
September 2, 2022
CompletedFirst Posted
Study publicly available on registry
September 7, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 2, 2022
CompletedSeptember 7, 2022
September 1, 2022
1.8 years
September 2, 2022
September 2, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Improvements in heart rate variability indices and rate of perceived exertion after intervention with telerehabilitation.
Heart rate variability indices measures through a cardiofrequencymeter and rate of perceived exertion through Borg scale before and after 10 session of telerehabilitation.
5 weeks
Secondary Outcomes (1)
Improvements in quality of life after intervention with telerehabilitation.
5 weeks
Study Arms (2)
Experimental Group
EXPERIMENTALWomen with breast cancer who will undergo the intervention with virtual game.
Control Group
ACTIVE COMPARATORHealthy women who will undergo the intervention with virtual game.
Interventions
It will be applied 10 sessions of remote rehabilitation in women with and without breast cancer, in order to promote physical activity.
Eligibility Criteria
You may qualify if:
- Female patients over 18 years old with a diagnosis of breast AC, who agree to participate in the research and present an understanding compatible with the execution of the procedures, will be invited to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Comitê de Ética da Universidade Federal
São Paulo, 04.023-900, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Talita D Silva, Ph.D.
University of Sao Paulo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher
Study Record Dates
First Submitted
September 2, 2022
First Posted
September 7, 2022
Study Start
March 2, 2020
Primary Completion
December 2, 2021
Study Completion
December 2, 2022
Last Updated
September 7, 2022
Record last verified: 2022-09